Correlation Between NewAmsterdam Pharma and Viracta Therapeutics

Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NewAmsterdam Pharma and Viracta Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Viracta Therapeutics.

Diversification Opportunities for NewAmsterdam Pharma and Viracta Therapeutics

0.37

Correlation Coefficient

NewAmsterdam Pharma  Viracta Therapeutics

Weak diversification

The 3 months correlation between NewAmsterdam and Viracta is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Viracta Therapeutics go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Viracta Therapeutics

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.13 times more return on investment than Viracta Therapeutics. However, NewAmsterdam Pharma is 7.55 times less risky than Viracta Therapeutics. It trades about -0.37 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.65 per unit of risk. If you would invest  2,261  in NewAmsterdam Pharma on November 28, 2024 and sell it today you would lose (473.00) from holding NewAmsterdam Pharma or give up 20.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	42.86%
Values	Daily Returns

NewAmsterdam Pharma  vs.  Viracta Therapeutics

NewAmsterdam Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days NewAmsterdam Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, NewAmsterdam Pharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Viracta Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viracta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with NewAmsterdam Pharma and Viracta Therapeutics

The main advantage of trading using opposite NewAmsterdam Pharma and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.

The idea behind NewAmsterdam Pharma and Viracta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.